I just googled it.. the Europeans had reached a conclusion that the Benefits do not outweigh the Risks.. oh.. did they look at Epogen..
Dumb & Idiot
Also says " we reserve the right to make further submissions" also monitored first use would solve these issues.
Sentiment: Strong Buy
Takeda withdrew the application due to impending investigation. Do you know still the Omontys trials are continuing in EU after 7+ years of Omonty's administration.
At this juncture since this is recalled, they will have to close this issue and will take it up once O's investigation is over and reintroduced.